Raimund Sprenger

Title: Raimund Sprenger: Innovator in Genetic Testing

Introduction

Raimund Sprenger is a notable inventor based in Weilheim, Germany. He has made significant contributions to the field of genetic testing, holding 2 patents that focus on methods for detecting genetic mutations. His work is particularly relevant in the context of patient susceptibility to toxins and therapeutic agents.

Latest Patents

Sprenger's latest patents include a method for determining the presence of at least one allele of a GSTT1 deletion mutant. This method involves a PCR assay designed to detect the presence of a GST1*0 allele. The process utilizes two primers, one from the sequence upstream of the deletion area and the other from the sequence downstream. The production of the corresponding DNA fragment in the PCR is then verified. This invention is useful for testing patients to assess their susceptibility to toxins or their sensitivity to certain therapeutic agents. Another patent focuses on a method for the introduction of foreign DNA into the genome of a target cell through homologous recombination. This method also addresses the homologous recombination of suitable DNA constructs.

Career Highlights

Throughout his career, Raimund Sprenger has worked with prominent companies in the biotechnology sector. Notable among these are Epidauros Biotechnologie AG and Roche Diagnostics GmbH. His experience in these organizations has contributed to his expertise in genetic testing and biotechnology innovations.

Collaborations

Sprenger has collaborated with esteemed colleagues, including Robert Schlagenhaufer and Ulrich Brinkmann. These partnerships have furthered his research and development efforts in the field of genetics.

Conclusion

Raimund Sprenger's contributions to genetic testing through his innovative patents highlight his role as a significant figure in biotechnology. His work continues to impact the understanding of genetic susceptibility and therapeutic responses in patients.